Hypertension prevalence, awareness, treatment and control among Han and four ethnic minorities (Uygur, Hui, Mongolian and Dai) in China

Journal of Human Hypertension

Volumn 29, Issue 9, 2015, Pages 555-560

  Gu, H ^a   Li, W ^a   Yang, J ^a   Wang, Y ^a   Bo, J ^a   Liu, L ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHINESE DRUG; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; HYDROCHLOROTHIAZIDE; RESERPINE; TRADITIONAL COMPOUND DRUG; UNCLASSIFIED DRUG;

ADULT; AGE; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CHINA; CHINESE MEDICINE; COMPARATIVE STUDY; CONTROLLED STUDY; CULTURAL ANTHROPOLOGY; DAI (PEOPLE); DRUG USE; EDUCATIONAL STATUS; ETHNIC GROUP; FEMALE; GEOGRAPHIC DISTRIBUTION; HAN CHINESE; HEALTH EDUCATION; HUI (PEOPLE); HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONGOLIAN (PEOPLE); PREVALENCE; SELF REPORT; SEX; UYGUR (PEOPLE); WESTERN MEDICINE; ASIAN CONTINENTAL ANCESTRY GROUP; ATTITUDE TO HEALTH; AWARENESS; BLOOD PRESSURE; DRUG EFFECTS; EPIDEMIOLOGY; ETHNOLOGY; HEALTH CARE SURVEY; MIDDLE AGED; MINORITY GROUP; MINORITY HEALTH; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; PSYCHOLOGY; QUESTIONNAIRE; TREATMENT OUTCOME;

ADULT; ANTIHYPERTENSIVE AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; AWARENESS; BLOOD PRESSURE; CHINA; FEMALE; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MINORITY GROUPS; MINORITY HEALTH; PREVALENCE; PROSPECTIVE STUDIES; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84939265115     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2014.123     Document Type: Article

References (25)

1. World Health Organization. Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. World Health Organization: Geneva, 2009.
2. Wang Q. High blood pressure a growing threat to China's public health[Internet]. China Daily (Beijing) c1995-2015. Available from: http://www.chinadaily.com.cn/ cndy/2013-04/08/content-16381678.html (cited 7 September 2014).
3. National Center for Cardiovascular Diseases. Report on Cardiovascular Disease in China (2007) [in Chinese]. Encyclopedia of China Publishing House: Beijing, 2007.
4. Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P et al. Prevalence, awareness, treatment, and control of hypertension in china. Hypertension 2002; 40(6): 920-927.
5. Wu Y, Huxley R, Li L, Anna V, Xie G, Yao C et al. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation 2008; 118(25): 2679-2686.
6. Chow CK. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 2013; 310(9): 959.
7. Chen Z, Meltzer D. Beefing up with the Chans: evidence for the effects of relative income and income inequality on health from the China Health and Nutrition Survey. Soc Sci Med 2008; 66(11): 2206-2217.
8. Teo K, Chow CK, Vaz M, Rangarajan S, Yusuf SGroup PI-W. The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. Am Heart J 2009; 158(1): 1-7 e1.
9. Gao Y, Chen G, Tian H, Lin L, Lu J, Weng J et al. Prevalence of hypertension in china: a cross-sectional study. PLoS ONE 2013; 8(6): e65938.
10. Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P et al. Prevalence, awareness, treatment, and control of hypertension in China. Hypertension 2002; 40(6): 920-927.
11. Tao S, Wu X, Duan X, Fang W, Hao J, Fan D et al. Hypertension prevalence and status of awareness, treatment and control in China. Chin Med J 1995; 108(7): 483-489.
12. Wang Z, Wang X, Chen Z, Wang W, Zhu H, Chen W et al. Hypertension control in community health centers across china: analysis of antihypertensive drug treatment patterns. Am J Hypertens 2014; 27: 252-259.
13. Yisong H, Chonghua Y, Wenzhi W, Jianpin H. Survey on the prevalence of hypertension in different ethnic groups in China in 2002. J Hypertens Res 2006; 35 (5): 573-575.
14. Ferdinand KC. Hypertension in minority populations. J Clin Hypertens 2006; 8(5): 365-368.
15. Centers for Disease Control. Prevention. Prevention. Racial/ethnic disparities in prevalence, treatment, and control of hypertension - United States, 1999-2002. MMWR Morb Mortal Wkly Rep 2005; 54(1): 7.
16. Yao X-G, Frommlet F, Zhou L, Zu F, Wang H-M, Yan Z-T et al. The prevalence of hypertension, obesity and dyslipidemia in individuals of over 30 years of age belonging to minorities from the pasture area of Xinjiang. BMC Public Health 2010; 10(1): 91.
17. Lu Z, Lu Z, Zhu Y, Yan Z, Liu X, Yan S et al. Enhanced hypertension prevalence in non-Han Chinese minorities from Xinjiang Province, China. Hypertens Res 2009; 32 (12): 1097-1103.
18. Yang S, Liu S, Wang Y, Wan H, Zhao D, Li Y et al. High blood pressure in Chinese ethnic minorities: report from rural Yunnan province. Am J Hypertens 2011; 24(11): 1209-1214.
19. He J, Klag MJ, Whelton PK, Chen JY, Mo JP, Qian MC et al. Migration, blood pressure pattern, and hypertension: the Yi Migrant Study. Am J Epidemiol 1991; 134(10): 1085-1101.
20. Black ML, Wang W, Bittles AH. A genome-based study of the Muslim Hui community and the Han population of Liaoning Province, PR China. Hum Biol 2001; 73 (6): 801-813.
21. Gu Q, Burt VL, Dillon CF, Yoon S. Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health and Nutrition Examination Survey, 2001 to 2010. Circulation 2012; 126(17): 2105-2114.
22. Ling RE, Liu F, Lu XQ, Wang W. Emerging issues in public health: a perspective on China's healthcare system. Public Health 2011; 125(1): 9-14.
23. Shao S, Zhao F, Wang J, Feng L, Lu X, Du J et al. The ecology of medical care in Beijing. PLoS ONE 2013; 8(12): e82446.
24. Liao Y, Tucker P, Okoro CA, Giles WH, Mokdad AH, Harris VB. REACH 2010 surveillance for health status in minority communities - -United States, 2001 - 2002. MMWR Surveill Summ 2004; 53(6): 1-36.
25. Zhang M, Meng Y, Yang Y, Liu Y, Dong C, Xiao J et al. Major inducing factors of hypertensive complications and the interventions required to reduce their prevalence: an epidemiological study of hypertension in a rural population in China. BMC Public Health 2011; 11(1): 301.